Skip to content

Advertisement

  • Study protocol
  • Open Access
  • Open Peer Review

The influence of surface EMG-triggered multichannel electrical stimulation on sensomotoric recovery in patients with lumbar disc herniation: study protocol for a randomized controlled trial (RECO)

Trials201718:566

https://doi.org/10.1186/s13063-017-2310-z

  • Received: 24 January 2017
  • Accepted: 3 November 2017
  • Published:
Open Peer Review reports

Abstract

Background

Intervertebral disc degeneration is one of the most common reasons for chronic low back pain and sensomotoric deficits, often treated by lumbar sequestrectomy. Nevertheless, the prognostic factors relevant for time and quality of recovery, of the surgical procedure, relative to conservative treatment, remain controversial and require further investigation. Surface electrical stimulation (SES) may be an influential intervention, already showing positive impact on motor and sensory recovery in different patient groups. Since mechanisms of SES still remain unclear, further inquiry is needed.

Methods/Design

This is a prospective, monocentric, randomized, controlled clinical trial. A total of 80 adult patients suffering from a lumbar disc herniation (LDH; 40 treated surgically, 40 conservatively) are allocated in a ratio of 1:1. Patients in the treatment group will receive surface electromyography (EMG)-triggered electrical stimulation for eight weeks, whereas patients in the control group will not obtain any additional treatment. The primary outcome parameter is defined as the cold detection threshold (CDT), determined by quantitative sensory testing (QST), 24 months after intervention. Secondary outcome parameters include the inquiry of sensory nerve function by two-point discrimination and QST, the assessment of motor nerve function by manual muscle testing, and validated scales and scores. These include: the Oswestry Disability Index (ODI) and the Core Outcome Measures Index (COMI) assessing the domains pain, back-specific function, work disability, and patient satisfaction; the EQ-5D investigating the patient’s generic health status; the painDETECT questionnaire (PD-Q) to identify neuropathic pain components; and the Beck Depression Inventory (BDI) to assess severity of depression. Moreover, neurological status, pain medication usage, and blood samples (CRP, TNFα, IL-1β, IL-6) will be evaluated. Study data generation (study site) and data storage, processing, and statistical analysis are clearly separated.

Discussion

The results of the RECO study will detect the effect of EMG-triggered multichannel SES on the improvement of mechanical and thermal sensitivity and the effect on motor recovery and pain, associated with clinical and laboratory parameters. Furthermore, data comparing surgical and conservative treatment can be collected. This will hopefully allow treatment recommendations for patients with LDH accompanied by a sensomotoric deficit.

Trial registration

ISRCTN, ISRCTN12741173. Registered on 15 January 2017.

Keywords

  • Lumbar disc herniation
  • Sensomotoric deficit
  • Sensomotoric recovery
  • Electrical stimulation
  • Quantitative sensory testing
  • Lumbar sequesterectomy

Background

Intervertebral disc degeneration (IVDD) represents one of the most common reasons for low back pain (LBP), which is an increasing medical and socioeconomic problem in industrialized countries. Of the German population, 85% suffer from severe LBP at least once in their lifetime [28]. IVDD may present as lumbar disc herniation (LDH) that compresses a spinal nerve root and may lead to sensory and motor deficits. A surgical decompression of the spinal nerve root is often required in these cases. Lumbar sequestrectomy is the standard surgical procedure being performed in patients with radiculopathy caused by a prolapsed lumbar disc [31]. Nevertheless, a subsequent physical therapy to support the recovery of deficits may be needed.

A LDH, however, may regress over time with conservative treatment without the need for surgical intervention [26]. Several studies [3, 21, 37] have compared surgical to non-surgical treatment in patients with herniated discs, the SPORTS-Trial being widely quoted as a seminal article in this field of research [38]. Surgically and conservatively treated patients improved substantially over a period of 24 months. Due to a few limitations, conclusions on the superiority or equivalence of each treatment could not be drawn and further investigation is needed [38].

The patient’s sensory and motor recovery after a LDH, whether treated surgically or not, is influenced by various factors like gender, pain, duration, and severity of paresis [14, 22, 34]. Further parameters include: the degree of nerve root compression; functional recovery of nerve fibers; and potentially denervated muscle areas [27]. Electromyography (EMG)-triggered surface electrical stimulation (SES) is an intervention combining electrical biofeedback of muscles with neuromuscular electrical stimulation. It is known to be effective in improving weakness of paretic muscles and remodeling the function of the related nervous system [40]. SES is frequently used to further improve motor function in severe central and peripheral paresis, as muscle atrophy due to damage on the innervating nerve is prevented by active and passive stimulation of the muscle, as well as stimulation of the according nerve [2, 9, 19, 23, 30]. Previous studies not only showed a positive influence of electrical stimulation on promotion of peripheral nerve regeneration after injury in humans and animals [11, 15, 39], but also showed an increase in strength and muscle size in healthy subjects [20]. Additionally, patients with painful IVDD show elevated IL-6 and TNF-α levels not only in the IVDD itself [7, 17], but also in serum [36]. Electrical stimulation may lead to a downregulation of these pro-inflammatory cytokines [8, 33]. Nevertheless, the underlying mechanism of SES and its influence on sensomotoric recovery are still unclear and require further investigation.

So far, improvement of sensory and motor nerve function supported by SES has been infrequently subjected to well-designed clinical trials. Thus, there is a need for data with validated modern spinal outcome instruments (i.e. quantitative sensory testing [QST], objectively assessed muscle force, and patient’s self-assessment regarding satisfaction and ability). The objective of this prospective clinical trial is thus to evaluate the efficacy of EMG-triggered SES on sensomotoric recovery in patients with LDH, treated either conservatively or surgically, using validated modern spinal outcome instruments.

Methods/Design

Study design

The RECO-Study is a prospective, monocentric, randomized, controlled clinical trial. The study objective is to evaluate the improvement of sensory and motor nerve function in patients two years after either lumbar sequestrectomy (Population 1) or conservatively treated patients for LDH (Population 2), following the application of SES in the early stages of recovery (within two months after diagnosis or treatment decision). As the functional status, as well as sensory recovery parameters, are known to be assessed after two years of follow-up, this specific endpoint was also chosen for our study [12, 38, 41]. Randomization will be performed for application of electrical stimulation and therapy of recovery, but not for initial therapy of LDH. Outcome is assessed by QST [25], two-point discrimination testing (2PD) [32], manual muscle testing (MMT) [16], magnetic resonance imaging (MRI) parameters [18, 24], and by validated scales and scores. These include the Oswestry Disability Index (ODI) [6] and the Core Outcome Measures Index (COMI) [4] that are applied to assess the domains pain, back-specific function, work disability, and patient satisfaction. The generic health status is investigated with the EQ-5D [5]. Neuropathic pain components are identified with the painDETECT questionnaire (PD-Q) [10]. The severity of depression is assessed by the Beck Depression Inventory (BDI) [29]. Moreover, neurological status, muscle force, pain medication usage, and blood samples (CRP, TNFα, IL-1β, IL-6) [17, 35] will be evaluated. Furthermore, the timed up and go test (TUG) [13] will be performed. Primary and secondary outcome parameters are outlined in Additional file 1: Table S1.

Trial organization, registration, and ethical aspects

Ethics approval was obtained from the committee of the Local Ethics Committee. This study complies with the World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects, 2004, with Good Clinical Practice (GCP) and meets local laws and regulations including any and all applicable data privacy laws and regulations relating to the conduct of the study.

Study population

The study protocol aims to include patients who suffer from a LDH with radiculopathy and a sensomotoric nerve dysfunction. Patients are naturally divided into two groups, whether their individual condition qualifies them for lumbar sequestrectomy according to the guidelines of DGNC and DGOOC (Population 1) or for initial conservative treatment (Population 2). If conservative treatment (including usage of pain medication according to the WHO level scheme and physiotherapy for all, and epidural steroid injection in exceptional cases, like therapy refractory radicular pain without motor deficit) is inefficient for more than six weeks, or if patients suffer from a severe paresis, surgical treatment will be performed. Population 2 is thus allowed to cross over to Population 1. Surgically treated patients will receive postoperative pain therapy according to the WHO level scheme but no additional active physiotherapy in the first eight weeks after surgery, except SES. Radiculopathy is defined as pain, paresis (muscle strength grade 4 or less), or a sensory dysfunction in a specific nerve root distribution area L3 to S1. Additionally, a radiologically determined pathology at treatment level investigated by MRI needs to correlate to the clinical symptoms. To minimize risk factors for an unfavorable outcome, patients with significant co-morbidities (see inclusion and exclusion criteria in, Additional file 2: Table S2) need to be excluded, as this may mask a difference in treatment efficacy. Informed consent is obtained from each participant.

Timetable

Timetable and visit plan are outlined in Fig. 1.
Fig. 1
Fig. 1

Visit plan. Detailed itemization of planned follow-ups and actions taken

Surface electrical stimulation

After a guideline-dependent decision of the initial treatment for LDH, patients will be randomized into two groups, respectively, in a 1:1 allocation ratio: 20 patients (50%) in Population 1 and 20 patients (50%) in Population 2 will receive SES, whereas the other half will follow standardized treatment algorithms adjusted to the initially chosen therapy for LDH (see Additional file 3: Figure S1).

Stimulation is initially applied within three days post intervention. Patients are trained by the clinical investigator(s) at the study site to ensure proper usage of the stimulation device. Patients are then requested to perform treatment at home. Five electrodes (4 × 6.4 cm PALS latex-free neurostimulation electrodes, model 896230) are placed on the skin in the affected nerve root distribution area L3 to S1, according to instructions documented in the patient’s individual manual. For better comparability, standardized characteristic muscles for each nerve root are chosen for stimulation. M. quadriceps femoris covers distribution areas of the roots L3 and L4, M. tibialis anterior covers L5, and M. gastrocnemius is innervated by S1. Four electrodes are used to cover an as wide as possible area of each muscle, the fifth electrode is used for reference of the EMG capacity and is closely placed to bony structure (femur condyles or ankle) (see Additional file 4: Figure S2). The electrode surface of 25.6 cm2was chosen according to the volume of the stimulated muscles. The stimulation device (STIWELL med4, MED-EL) is started and the pre-set program (pulse width = 300 μs, frequency = 30 Hz, plateau time = 8 s, pause time = 16 s, rise time = 2 s, fall time = 2 s) is chosen. This program was developed with STIWELL specialists in the field of clinical rehabilitation and was adjusted on the condition’s special indications and expectations of recovery. The intensity will be increased until the patient feels and sees muscle contraction. If motor habituation appears, patients are instructed to increase the intensity until the comfortable tingling sensation and/or muscle contraction can be seen again. EMG triggers are imparted over the devices’ display and clearly signal the patient when to actively tense her/his muscles and when to pause. Thresholds for the EMG trigger are set at the maximum amount of electrical activity the patient is able to create. The device is set on automatic mode, which adjusts the threshold up after a successful trial or regulates it down after an unsuccessful one. Patients are instructed to perform this treatment for 1 h daily (2 × 30 min) for the following eight weeks. Time, date, and duration of each treatment should be noted in a provided document and handed out to the investigators at the next follow-up. Furthermore, treatment time, duration, and EMG thresholds can be read out directly from the device to surveil the patient’s compliance. If the treatment is conceived uncomfortable or skin irritation appears, patients are requested to immediately contact the clinical investigators.

Sequestrectomy

Surgery is performed after induction of general endotracheal anesthesia and with the assistance of an operating microscope, while the patient is in a prone position. Surgery is performed by two trial designated surgeons in a standardized manner. The spinal canal harboring the sequestrated disc material is exposed by performing a minimal inter-laminar fenestration to avoid removal of bone and articular structures. Based on results of a previous trial, only the herniated material is removed. The herniated space is not entered whenever possible [1, 31].

Randomization

The allocation ratio within groups is 1:1 (see Additional file 3: Figure S1). The randomization code will be generated independently from the clinical investigators according to a random permuted blocks method with varying block size. Statistical Software Stata 10.0 module Ralloc version 3.5.2 (Statacorp College Station, TX, USA) will be used to generate the random code. An independent statistician will administer the randomization code.

Data management

Study data generation done by the clinical investigators (SL, CW, SH, WL, AT) at the study site (Department of Neurosurgery) and data storage, processing, and statistical analysis performed by the cooperating partners (SN) at the Department of Medical Statistics, Informatics and Health Economics are clearly separated. A validated database system programmed in a customized software package, which is provided by the Department of Medical Statistics, Informatics and Health Economics, is available. The evaluation of the data takes place by double-entry of the data and manual/visual evaluation of plausibility. After entry of all collected data and clarification of all queries, the database will be closed at the completion of the study.

Sample size calculation

Sample size calculation is based on the primary endpoint of the study, the cold detection threshold (CDT) two years post intervention. Relevant data were acquired from previous prospective trials at our center, also using the CDT as a primary outcome parameter. Sixty-three patients are required to detect a difference of 3.4 considering a standard deviation (SD) of 6.8 with 80% power on a two-sided level of significance of 0.05. We considered a loss to follow-up < 20% adequate for final calculation of sample size, which is 75–80 patients.

Statistical analyses

All statistical analyses will be performed in consultation with the Department of Medical Statistics and Health Economics, Innsbruck Medical University, Innsbruck, Austria. Detailed descriptive statistics will be provided for the data collected and 95% confidence intervals will be calculated for all relevant estimates. The primary analysis will follow as the randomized principle. All patients with a complete pre-treatment examination will be considered for inclusion into the population. Primary outcome parameter will be the CDT. We estimate that the 24 months change of the CDT in patients treated without SES will be approximately 10%, whereas patients treated with SES should show a better improvement up to 20% of the initial threshold. In a one-way analysis of variance (ANOVA) test, group sample sizes of 35 patients in each group achieve 80% power to detect a significant difference between the CDT estimates with an estimated standard deviation of 20%. To adjust for multiple pairwise comparisons, the critical p value for statistical significance was adjusted to p ≤ 0.05. Descriptive analyses will include reporting means (with SDs) for continuous variables and frequencies (with percentages) for discrete variables. One-way analysis of variance (or non-parametric Kruskal–Wallis equivalent) will be used to assess the difference in the primary outcome of CDT between those patients that received conventional therapy (without SES) and those who received SES. Differences between each patient, compared to the not affected body site, will be analyzed using paired t-test to adjust for the clustered nature of the thresholds for each patient.

Discussion

Sensory and motor nerve function improvement following LDH, especially the influence on time and the quality of recovery, are infrequently subjected to well-designed clinical trials. There is a need for data with validated modern outcome instruments to assess evidence-based prognosis for patients with sensomotoric dysfunction. The results of this study will detect the effect of EMG-triggered multichannel SES on the improvement of mechanical and thermal sensitivity and the effect on motor recovery and pain, associated with clinical and laboratory parameters. Furthermore, additional influencing factors on sensomotoric recovery may be identified and will hopefully lead allow treatment recommendations for patients with LDH accompanied by a sensomotoric deficit.

To guarantee a high scientific value, the outcome instruments used in this trial are adjusted to the latest standards in the literature among spinal and neurologic investigations. The QST is a valuable instrument for the objectification of sensory function [25, 34]. The MMT also depicts a highly valuable tool for the quantification of muscle power and therefore we utilize the possibility to avoid an investigator’s bias, not considered in most of the previous trials. Our patient’s self-assessment (ODI, EQ5D, COMI, PD-Q, BDI) matches the highest standards of the middle European assessments for quality of life and consequently subjective efficacy of spinal procedures and management options. Patients are treated in a standardized manner and are therefore well comparable. All quantitative values can be compared between the initial treatment groups (conservative or operative) as well as between the therapy groups (SES or non-SES) and, additionally, within each patient by collecting and comparing data bilaterally (affected and non-affected side). Furthermore, our SES program was developed with leading clinical specialists and therefore matches the latest standards and innovations. Devices are especially programmed so that after the scheduled application of the medical device, individual usage times and thresholds can be read and considered by the clinical investigators.

Limitations of our trial include the expected cross-over from group conservative to group operative, as recruitment may prevail in favor of surgically treated patients. Furthermore, patients initially treated medically and randomized to the group receiving SES, will start the surgical treatment with potentially already influenced sensomotoric function. Nevertheless, before the operation a QST will be done and values will provide as reference.

Altogether, our trial was designed responsibly by experienced investigators from diverse specialties and is expected to deliver highly qualitative results in the first prospective clinical trial investigating the influence of EMG-triggered SES on the sensory and motoric recovery in patients suffering from LDH. Additionally, we expect to supply relevant outcome data on both conservative and operative management to prospectively identify a superior treatment method for symptomatic LDH.

Trial status

Recruitment is planned to be started in October 2017, as soon as the authority’s clearance is available.

Abbreviations

ANCOVA: 

Analysis of covariance

DGNC: 

German Society of Neurosurgery

DGOOC: 

German Society of Orthopaedics and Orthopaedic Surgery

EMG: 

Electromyography

MRC: 

Medical Research Council

MRI: 

Magnetic resonance imaging

WHO: 

World Health Organization

Declarations

Acknowledgements

Electronic devices are provided by MED-EL (MED-EL Medical Electronics, Fuerstenweg 44a, 6020 Innsbruck, Austria). We thank Prof. Dr. Elke Gizewski (Department of Neuroradiology, Medical University Innsbruck) for the imaging support; and Kathi Jeller and Ulli Tripp (Department of Neurology, Medical University Innsbruck) for their overall support.

Funding

Academic study – no funding.

Availability of data and materials

See cited.

Authors’ contributions

SL and AT wrote the manuscript together with CT. SH and CW made substantial coordination of the trial. WNL gave substantial contribution to conception. MW supervised imaging support. SN consulted in drafting the statistical part of the protocol and revised it critically. All authors made substantial contribution to the conception and design of the manuscript. All authors have read and approved this manuscript.

Ethics approval and consent to participate

Ethics approval given by the Ethics Committee of the Innsbruck Medical University on 16 November 2016 (reference no. AN2016-0103 362/4.14, protocol version 1.0, 15.05.2016). Find the English version (Jan 08 2017) attached. Informed consent from all participants will be obtained.

Consent for publication

The results of this clinical trial will be published. Pseudonymity of the patients will be maintained. The principal investigator is responsible for listing the authors.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Neurosurgery, Innsbruck Medical University, Anichstr. 35, 6020 Innsbruck, Austria
(2)
Department of Neurology, Innsbruck Medical University, Innsbruck, Austria
(3)
Department of Medical Statistics and Health Economics, Innsbruck Medical University, Innsbruck, Austria
(4)
Department of Neuroradiology, Innsbruck Medical University, Innsbruck, Austria

References

  1. Barth M, Diepers M, Weiss C, Thomé C. Two-year outcome after lumbar microdiscectomy versus microscopic sequestrectomy: part 2: radiographic evaluation and correlation with clinical outcome. Spine (Phila Pa 1976). 2008;33:273–9.View ArticleGoogle Scholar
  2. Bertoti DB. Electrical stimulation: a reflection on current clinical practices. Assist Technol. 2000;12(1):21–32.View ArticlePubMedGoogle Scholar
  3. Buttermann GR. Treatment of lumbar disc herniation: epidural steroid injection compared with discectomy. A prospective, randomized study. J Bone Joint Surg Am. 2004;86-A(4):670–9.View ArticlePubMedGoogle Scholar
  4. Deyo RA, Nachemson A, Mirza SK. Spinal-fusion surgery—the case for restraint. N Engl J Med. 2004;350:722–6.Google Scholar
  5. EuroQol Group. EuroQol--a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199–208.View ArticleGoogle Scholar
  6. Fairbank JC, Pynsent PB. The Oswestry Disability Index. Spine (Phila Pa 1976). 2000;25(22):2940–52.Google Scholar
  7. Fang F, Jiang D. IL-1β/HMGB1 signalling promotes the inflammatory cytokines release via TLR signalling in human intervertebral disc cells. Biosci Rep. 2016;36(5):e00379.View ArticlePubMedPubMed CentralGoogle Scholar
  8. Fiorelli A, Morgillo F, Milione R, Pace MC, Passavanti MB, Laperuta P, et al. Control of post-thoracotomy pain by transcutaneous electrical nerve stimulation: effect on serum cytokine levels, visual analogue scale, pulmonary function and medication. Eur J Cardiothor Surg. 2012;41:861–8.View ArticleGoogle Scholar
  9. Foecking EM, Fargo KN, Coughlin LM, Kim JT, Marzo SJ, Jones KJ. Single session of brief electrical stimulation immediately following crush injury enhances functional recovery of rat facial nerve. J Rehabil Res Dev. 2012;49(3):451–8.View ArticlePubMedGoogle Scholar
  10. Freynhagen R, Baron R, Gockel U, Tölle TR. painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin. 2006;22:1911–20.View ArticlePubMedGoogle Scholar
  11. Gordon T. Electrical stimulation to enhance axon regeneration after peripheral nerve injuries in animal models and humans. Neurotherapeutics. 2016;13(2):295–310.View ArticlePubMedPubMed CentralGoogle Scholar
  12. Grøvle L, Haugen AJ, Natvig B, Brox JI, Grotle M. The prognosis of self-reported paresthesia and weakness in disc-related sciatica. Eur Spine J. 2013;22(11):2488–95.View ArticlePubMedPubMed CentralGoogle Scholar
  13. Hartmann S, Hegewald AA, Tschugg A, Neururer S, Abenhardt M, Thomé C. Analysis of a performance-based functional test in comparison with the visual analog scale for postoperative outcome assessment after lumbar spondylodesis. Eur Spine J. 2016;25(5):1620–6.View ArticlePubMedGoogle Scholar
  14. Hebert JJ, Fritz JM, Koppenhaver SL, Thackeray A, Kjaer P. Predictors of clinical outcome following lumbar disc surgery: the value of historical, physical examination, and muscle function variables. Eur Spine J. 2016;25(1):310–7.View ArticlePubMedGoogle Scholar
  15. Huang J, Zhang Y, Lu L, Hu X, Luo Z. Electrical stimulation accelerates nerve regeneration and functional recovery in delayed peripheral nerve injury in rats. Eur J Neurosci. 2013;38(12):3691–701.View ArticlePubMedGoogle Scholar
  16. Le-Ngoc L, Janssen J. Validity and reliability of a hand-held dynamometer for dynamic muscle strength assessment. In: Kim C-T, editor. Rehabilitation Medicine. InTech. 2012. https://www.intechopen.com/books/rehabilitation-medicine/validity-and-reliability-of-a-hand-held-dynamometer-for-dynamic-muscle-strength-assessment. Accessed 15 May 2016.
  17. Mern DS, Beierfuβ A, Fontana J, Thomé C, Hegewald AA. Imbalanced protein expression patterns of anabolic, catabolic, anti-catabolic and inflammatory cytokines in degenerative cervical disc cells: new indications for gene therapeutic treatments of cervical disc diseases. PLoS One. 2014;9(5):e96870.View ArticlePubMedPubMed CentralGoogle Scholar
  18. Modic MT, Steinberg PM, Ross JS, Masaryk TJ, Carter JR. Degenerative disk disease: assessment of changes in vertebral body marrow with MR imaging. Radiology. 1988;166:193–9.View ArticlePubMedGoogle Scholar
  19. Ng SS, Hui-Chan CW. Transcutaneous electrical nerve stimulation combined with task-related training improves lower limb functions in subjects with chronic stroke. Stroke. 2007;38(11):2953–9.View ArticlePubMedGoogle Scholar
  20. Onigbinde AT, Adeloye OO, Akindoyin O, Nesto T. Effects of motor-level transcutaneous electrical nerve stimulation on ipsilateral and un-stimulated contralateral quadriceps femoris. Technol Health Care. 2014;22(5):759–66.PubMedGoogle Scholar
  21. Overdevest GM, Vleggeert-Lankamp CL, Jacobs WC, Brand R, Koes BW, Peul WC. Recovery of motor deficit accompanying sciatica--subgroup analysis of a randomized controlled trial. Spine J. 2014;14(9):1817–24.View ArticlePubMedGoogle Scholar
  22. Petr O, Glodny B, Brawanski K, Kerschbaumer J, Freyschlag C, Pinggera D, et al. Immediate versus delayed surgical treatment of lumbar disc herniation for acute motor deficits: the impact of surgical timing on functional outcome. Spine (Phila Pa 1976). 2017. http://doi.org/10.1097/BRS.0000000000002295.
  23. Pockett S, Pygott V. Chronic nerve stimulation increases quantal output in rat muscles. Exp Neurol. 1982;78(2):477–80.View ArticlePubMedGoogle Scholar
  24. Pfirrmann CW, Metzdorf A, Zanetti M, Hodler J, Boos N. Magnetic resonance classification of lumbar intervertebral disc degeneration. Spine (Phila Pa 1976). 2001;26:1873–8.View ArticleGoogle Scholar
  25. Rolke R, Baron R, Maier C, Tolle TR, Treede RD, Beyer A, et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. Pain. 2006;123:231–43.View ArticlePubMedGoogle Scholar
  26. Saal JA, Saal JS. Nonoperative treatment of herniated lumbar intervertebral disc with radiculopathy. An outcome study. Spine (Phila Pa 1976). 1989;14(4):431–7.View ArticleGoogle Scholar
  27. Schiff E, Eisenberg E. Can quantitative sensory testing predict the outcome of epidural steroid injections in sciatica? A preliminary study. Anesth Analg. 2003;97(3):828–32.View ArticlePubMedGoogle Scholar
  28. Schmidt CO, Raspe H, Pfingsten M, Hasenbring M, Basler HD, Eich W, et al. Back pain in the German adult population. Spine. 2007;18:2005–11.View ArticleGoogle Scholar
  29. Smarr KL, Keefer AL. Measures of depression and depressive symptoms: Beck Depression Inventory-II (BDI-II), Center for Epidemiologic Studies Depression Scale (CES-D), Geriatric Depression Scale (GDS), Hospital Anxiety and Depression Scale (HADS), and Patient Health Questionnaire-9 (PHQ-9). Arthritis Care Res (Hoboken). 2011;63 Suppl 11:454–66.View ArticleGoogle Scholar
  30. Springer S, Laufer Y, Becher M, Vatine JJ. Dual-channel functional electrical stimulation improvements in speed-based gait classifications. Clin Interv Aging. 2013;8:271–7.View ArticlePubMedPubMed CentralGoogle Scholar
  31. Thomé C, Barth M, Scharf J, Schmiedek P. Outcome after lumbar sequestrectomy compared with microdiscectomy: a prospective randomized study. J Neurosurg Spine. 2005;2:271–8.View ArticlePubMedGoogle Scholar
  32. Tong J, Mao O, Goldreich D. Two-point orientation discrimination versus the traditional two-point test for tactile spatial acuity assessment. Front Hum Neurosci. 2013;7:579.View ArticlePubMedPubMed CentralGoogle Scholar
  33. Truong AD, Kho ME, Brower RG, Feldman DR, Colantuoni E, Needham DM. Effects of neuromuscular electrical stimulation on cytokines in peripheral blood for healthy participants: a prospective, single-blinded study. Clin Physiol Funct Imaging. 2017;37:255–62.View ArticlePubMedGoogle Scholar
  34. Tschugg A, Löscher WN, Hartmann S, Neururer S, Wildauer M, Thomé C. Gender influences radicular pain perception in patients with lumbar disc herniation. J Womens Health (Larchmt). 2015;24(9):771–6.View ArticleGoogle Scholar
  35. Tschugg A, Diepers M, Simone S, Michnacs F, Quirbach S, Strowitzki M, et al. A prospective randomized multicenter phase I/II clinical trial to evaluate safety and efficacy of NOVOCART disk plus autologous disk chondrocyte transplantation in the treatment of nucleotomized and degenerative lumbar disks to avoid secondary disease: safety results of Phase I-a short report. Neurosurg Rev. 2017;40:155–62.View ArticlePubMedGoogle Scholar
  36. Wang K, Bao JP, Yang S, Hong X, Liu L, Xie XH, et al. A cohort study comparing the serum levels of pro- or anti-inflammatory cytokines in patients with lumbar radicular pain and healthy subjects. Eur Spine J. 2016;25(5):1428–34.View ArticlePubMedGoogle Scholar
  37. Weber H. Lumbar disc herniation. A controlled, prospective study with ten years of observation. Spine (Phila Pa 1976). 1983;8(2):131–40.View ArticleGoogle Scholar
  38. Weinstein JN, Tosteson TD, Lurie JD, Tosteson AN, Hanscom B, Skinner JS, et al. Surgical vs nonoperative treatment for lumbar disk herniation: the Spine Patient Outcomes Research Trial (SPORT): a randomized trial. JAMA. 2006;296(20):2441–50.View ArticlePubMedPubMed CentralGoogle Scholar
  39. Wilder RP, Wind TC, Jones EV, Crider BE, Edlich RF. Functional electrical stimulation for a dropped foot. J Long Term Eff Med Implants. 2002;12(3):149–59.PubMedGoogle Scholar
  40. Xu H, Jie J, Hailiang Z, Ma C. Effect of EMG-triggered stimulation combined with comprehensive rehabilitation training on muscle tension in poststroke hemiparetic patients. J Sports Med Phys Fitness. 2015;55(11):1343–7.PubMedGoogle Scholar
  41. Yu PF, Jiang FD, Liu JT, Jiang H. Outcomes of conservative treatment for ruptured lumbar disc herniation. Acta Orthop Belg. 2013;79(6):726–30.PubMedGoogle Scholar

Copyright

© The Author(s). 2017

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate. Please note that comments may be removed without notice if they are flagged by another user or do not comply with our community guidelines.

Advertisement